logo image
search icon
Global Point of Care Diagnostics Market

Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Platform (Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays), Dipsticks, Microfluidics, Molecular Diagnostic), Product, Mode, End-Users, Region, And Segment Forecasts, 2023-2031.

Report ID : 1033 | Published : 2023-06-17 | Pages: 150 | Format: PDF/EXCEL

The Point of Care Diagnostics Market Size is valued at 45003.0 Million in 2022 and is predicted to reach 89209.1 Million by the year 2031 at an 8.0 % CAGR during the forecast period for 2023-2031.

Point of Care Diagnostics Market

Point-Of-Care diagnostic devices are used for early and quick diagnosis of diseases. These techniques are highly sensitive, cost-effective, and produce immediate results. Point-of-care diagnostics have many advantages in the physician’s office, home healthcare, research laboratory, and in the hospital. One of the major factors responsible for the growth of this market are the rising prevalence of chronic and infectious diseases all over the world. Moreover, the COVID-19 pandemic has significantly affected the point of care diagnostics market. An increasing number of COVID-19 patients forcing the healthcare industry to develop rapid and advance testing tools, driving the opportunities for POC market.

High prevalence of infectious diseases, rising human health issues, need for rapid diagnostics, lack of advanced technologies in the diagnostic labs, growing preference for home healthcare, new inventions and innovations by key players, changes in lifestyle patterns, and increasing healthcare expenditure will create more opportunities to expand the point of care diagnostics market during the forecast period.

Market Segmentation

The point of care diagnostics market can be segmented on the basis of products, Platform, mode, end-users, and region. On the basis of products, the market can be divided into Blood Glucose Monitoring Testing Products, Cardiac Metabolism Monitoring Testing Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy, and Fertility Testing Product, Fecal Occult Testing Products, Hematology Testing Products, Tumor/Cancer Markers Testing Products, Drugs of Abuse Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, and other PoC Testing Products. The infectious disease testing products segment has dominated the POC market in 2020 and will also lead the market throughout the forecast period 2019-2030. The glucose product segment is also in high demand as the routine testing of glucose levels is very important for controlling diabetics. Based on the Platform, the market can be segmented into Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays), Dipsticks, Microfluidics, and Molecular Diagnostic. The market for the Lateral Flow Assays segment is expected to dominate in the future. 

In terms of mode, the market is divided into prescription-based Testing Products and Over-the-Counter (OTC) Testing Products. Demand for rapid detection tools and the high prevalence of diseases will enhance the Over-the-Counter (OTC) testing product segment during the forecast period. By end-users, the market is divided into Home Care/Self-Testing, Physician offices & Outpatient/Ambulatory Care Settings, Hospitals, and Research Laboratories. The Home Care/Self-Testing end-use segment is expected growth faster during 2019-2030 as this segment is making disease detection easier, faster and instant.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East, and Africa. During the forecast period 2019-2030, North America is expected to dominate the POC diagnostics market due to the growing prevalence of chronic and infectious diseases, and rising government initiatives in this region.

Competitive Landscape

Some of The Key Players in The Point of Care Diagnostics Market:

  • Abbott Laboratories
  • Dickinson, And Company (Bd)
  • Chembio Diagnostic Systems, Inc.
  • Danaher Corporation
  • Ekf Diagnostics Holdings Plc
  • Werfenlife, S.A.
  • Johnson & Johnson Services, Inc.
  • Nova Biomedical
  • Hoffmann-La Roche Ltd.
  • Sekisui Chemical Co. Ltd.
  • Quidel Corporation
  • Siemens Ag
  • Trinity Biotech
  • Accubiotech Co., Ltd.
  • Other Key Players

The Point of Care Diagnostics Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 45003.0 Million

Revenue Forecast In 2031

USD 89209.1 Million

Growth Rate CAGR

CAGR of 8.0 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Platform, By Product, By Mode, By End-Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., Johnson & Johnson Services, Inc., Hoffmann-La Roche Ltd., Sekisui Chemical Co. Ltd., Dickinson, And Company (Bd), Quidel Corporation, Siemens Ag, Trinity Biotech, Accubiotech Co., Ltd., and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Point of Care Diagnostics Market Snapshot

Chapter 4. Global Point of Care Diagnostics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis

5.1. By Product & Market Share, 2022 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Product:

5.2.1. Blood Glucose Monitoring Testing Products

5.2.2. Cardiac Metabolism Monitoring Testing Products

5.2.3. Infectious Disease Testing Products

5.2.4. Coagulation Monitoring Products

5.2.5. Pregnancy and Fertility Testing Product

5.2.6. Fecal Occult Testing Products

5.2.7. Hematology Testing Products

5.2.8. Tumor/Cancer Markers Testing Products

5.2.9. Drugs of Abuse Testing Products

5.2.10. Urinalysis Testing Products

5.2.11. Cholesterol Testing Products

5.2.12. Other PoC Testing Products

Chapter 6. Market Segmentation 2: By Platform Estimates & Trend Analysis

6.1. By Platform & Market Share, 2022 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Platform:

6.2.1. Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)

6.2.2. Dipsticks

6.2.3. Microfluidics

6.2.4. Molecular Diagnostic

Chapter 7. Market Segmentation 3: By Mode Estimates & Trend Analysis

7.1. By Mode & Market Share, 2022& 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Mode:

7.2.1. Prescription-Based Testing Products

7.2.2. Over-the-Counter (OTC) Testing Product

Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis

8.1. By End-User & Market Share, 2022& 2030

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By End-User:

8.2.1. Home Care/Self Testing

8.2.2. Physician offices & Outpatient/Ambulatory Care Settings

8.2.3. Hospitals

8.2.4. Research Laboratories

Chapter 9. Point of Care Diagnostics Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By Product, 2022 - 2030

9.1.2. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By Platform, 2022 - 2030

9.1.3. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By Mode, 2022 – 2030

9.1.4. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

9.1.5. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030

9.2. Europe

9.2.1. Europe Point of Care Diagnostics Market revenue (US$ Million) By Product, 2022 - 2030

9.2.2. Europe Point of Care Diagnostics Market revenue (US$ Million) By Platform, 2022 - 2030

9.2.3. Europe Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By Mode, 2022 – 2030

9.2.4. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

9.2.5. Europe Point of Care Diagnostics Market revenue (US$ Million) by country, 2022 - 2030

9.3. Asia Pacific

9.3.1. Asia Pacific Point of Care Diagnostics Market revenue (US$ Million) By Product, 2022 - 2030

9.3.2. Asia Pacific Point of Care Diagnostics Market revenue (US$ Million) By Platform, 2022 - 2030

9.3.3. Asia Pacific Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By Mode, 2022 – 2030

9.3.4. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

9.3.5. Asia Pacific Point of Care Diagnostics Market revenue (US$ Million) by country, 2022 - 2030

9.4. Latin America

9.4.1. Latin America Point of Care Diagnostics Market revenue (US$ Million) By Product, (US$ Million)

9.4.2. Latin America Point of Care Diagnostics Market revenue (US$ Million) By Platform, (US$ Million)

9.4.3. Latin America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By Mode, 2022 – 2030

9.4.4. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

9.4.5. Latin America Point of Care Diagnostics Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Point of Care Diagnostics Market revenue (US$ Million) By Product, (US$ Million)

9.5.2. Middle East & Africa Point of Care Diagnostics Market revenue (US$ Million) By Platform, (US$ Million)

9.5.3. Middle East & Africa Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By Mode, 2022 – 2030

9.5.4. North America Point of Care Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

9.5.5. Middle East & Africa Point of Care Diagnostics Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Abbott Laboratories

10.2.2. Dickinson, And Company (Bd)

10.2.3. Chembio Diagnostic Systems, Inc.

10.2.4. Danaher Corporation

10.2.5. Ekf Diagnostics Holdings Plc

10.2.6. Werfenlife, S.A.

10.2.7. Johnson & Johnson Services, Inc.

10.2.8. Nova Biomedical

10.2.9. Hoffmann-La Roche Ltd.

10.2.10. Sekisui Chemical Co. Ltd.

10.2.11. Quidel Corporation

10.2.12. Siemens Ag

10.2.13. Trinity Biotech

10.2.14. Accubiotech Co., Ltd.

10.2.15. Other Key Players

Global Point of Care Diagnostics Market Segmentation

Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Products

  • Blood Glucose Monitoring Testing Products
  • Cardiac Metabolism Monitoring Testing Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Pregnancy and Fertility Testing Product
  • Fecal Occult Testing Products
  • Hematology Testing Products
  • Tumor/Cancer Markers Testing Products
  • Drugs of Abuse Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Other PoC Testing Products

 

Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Platform

  • Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostic

Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Mode

  • Prescription-Based Testing Products
  • Over-the-Counter (OTC) Testing Product

Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on End-users

  • Home Care/Self Testing
  • Physician offices & Outpatient/Ambulatory Care Settings
  • Hospitals
  • Research Laboratories

Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Point of Care Diagnostics Market Revenue (US$ Million) by Country, 2019 to 2030

  • U.S.
  • Canada

Europe Point of Care Diagnostics Market Revenue (US$ Million) by Country, 2019 to 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) by Country, 2019 to 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Point of Care Diagnostics Market Revenue (US$ Million) by Country, 2019 to 2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) by Country, 2019 to 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Point of Care Diagnostics Market Size?

The Point of Care Diagnostics Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031.

Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., Johnson &

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$3986
$5786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach